Jefferies Financial Group Inc. Purchases 40,401 Shares of Surgery Partners, Inc. $SGRY

Jefferies Financial Group Inc. purchased a new position in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 40,401 shares of the company’s stock, valued at approximately $560,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Legal & General Group Plc purchased a new stake in Surgery Partners during the 2nd quarter worth about $1,205,000. Whitefort Capital Management LP purchased a new stake in Surgery Partners during the 2nd quarter worth about $15,142,378. Penn Capital Management Company LLC acquired a new position in Surgery Partners in the 2nd quarter valued at about $2,941,000. Corient Private Wealth LP acquired a new position in Surgery Partners in the 2nd quarter valued at about $1,211,000. Finally, Hsbc Holdings PLC raised its stake in Surgery Partners by 54.5% in the 2nd quarter. Hsbc Holdings PLC now owns 2,958,912 shares of the company’s stock valued at $48,912,000 after purchasing an additional 1,043,244 shares during the last quarter.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $26.95 on Monday. The company has a market cap of $3.53 billion, a P/E ratio of -39.63 and a beta of 1.85. The company has a quick ratio of 2.01, a current ratio of 2.17 and a debt-to-equity ratio of 1.03. Surgery Partners, Inc. has a 52 week low of $11.41 and a 52 week high of $27.23. The business has a fifty day simple moving average of $17.30 and a 200-day simple moving average of $15.10.

Surgery Partners (NASDAQ:SGRY – Get Free Report) last released its earnings results on Monday, November 9th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.11 by $0.05. Surgery Partners had a positive return on equity of 0.98% and a negative net margin of 2.59%. The firm had revenue of $815.30 million during the quarter, compared to analyst estimates of $820.96 million. During the same period in the prior year, the firm posted $0.13 earnings per share. The business’s quarterly revenue was down .8% compared to the same quarter last year. Equities research analysts forecast that Surgery Partners, Inc. will post 0.07 EPS for the current year.

Insider Buying and Selling

In related news, Director Teresa DeLuca acquired 10,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was bought at an average price of $14.35 per share, with a total value of $143,500.00. Following the purchase, the director directly owned 66,843 shares in the company, valued at $959,197.05. The trade was a 17.59% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a research note on Tuesday, August 11th. Raymond James Financial set a $23.50 price target on shares of Surgery Partners in a report on Monday, October 26th. Stonex Financial lowered shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 27th. Mizuho lowered shares of Surgery Partners from an “outperform” rating to a “neutral” rating and boosted their price objective for the company from $19.00 to $25.00 in a research report on Wednesday, November 11th. Finally, TD Cowen upped their price objective on shares of Surgery Partners from $23.50 to $25.00 and gave the company a “hold” rating in a research note on Wednesday, November 11th. Two investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Surgery Partners currently has a consensus rating of “Hold” and a consensus price target of $20.70.

View Our Latest Research Report on SGRY

About Surgery Partners

(Free Report)

Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.

See Also

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.